Current Drug Targets - Infectious Disorders

Vaccine Therapy for Hepatitis B Virus Carrier
pp. 93-101(9)
Authors: Akbar, Sk. Md. F.; Furukawa, Shinya; Horiike, Norio; Onji, Morikazu

Two Orthogonal Approaches to Overcome Multi-Drug Resistant HIV-1s: Development of Protease Inhibitors and Entry Inhibitors Based on CXCR4 Antagonists
pp. 103-110(8)
Authors: Tamamura, Hirokazu; Fujii, Nobutaka

Antiviral Properties of Quinolone-based Drugs
pp. 111-116(6)
Authors: Richter, Sara; Parolin, Cristina; Palumbo, Manlio; Palu, Giorgio

Candida and Candidiasis: The Cell Wall as a Potential Molecular Target for Antifungal Therapy
pp. 117-135(19)
Authors: Gozalbo, Daniel; Roig, Patricia; Villamon, Eva; Gil, Maria L.

Determining and Overcoming Resistance to HIV Protease Inhibitors
pp. 137-152(16)
Authors: Prejdova, Jana; Soucek, Milan; Konvalinka, Jan

Aminoglycoside Nephrotoxicity
pp. 153-162(10)
Authors: Rougier, F.; Claude, D.; Maurin, M.; Maire, P.

Novel Tissue and Cell Type-specific Gene / Drug Delivery System Using Surface Engineered Hepatitis B Virus Nano-particles
pp. 163-167(5)
Authors: Yamada, Tadanori; Ueda, Masakazu; Seno, Masaharu; Kondo, Akihiko; Tanizawa, Katsuyuki; Kuroda, Shun'ichi